/R E P E A T -- Media Advisory - The Economic Club of Canada: healthy canadians, healthy future/

OTTAWA, Feb. 8, 2018 /CNW/ - We are at a pivotal moment in the evolution of life sciences. For the first time in human history the ability to cure cancer is within our grasp thanks to revolutionary breakthroughs in gene therapy. But these life-saving and life-changing innovations are of little benefit if Canadians can't access them.

This Friday, Pamela Fralick, President of Innovative Medicines Canada, will speak to the Economic Club of Canada in Toronto about the Government of Canada's recent proposed policy changes to Canada's patented drug pricing regime, and the profound implications these could have for Canadian healthcare and life sciences for decades to come.

The event will be broadcast live over the internet at https://livestream.com/accounts/11514155/FEB9healthycanadianshealthyfuture

Innovative Medicines Canada President Pamela Fralick will be available for media interviews after the event.

WHO:	Speakers Pamela C. Fralick: President, Innovative Medicines Canada
	Moderator Wayne Critchley: Former Executive Director, PMPRB
	Panelists Brian Hilberdink: President, Novo Nordisk Canada Inc. Dr. Jason Field: President & CEO, Life Sciences Ontario Janet Yale: President & CEO, The Arthritis Society of Canada
WHEN:	Friday, February 9, 2018 (11:30 a.m. - 1:30 p.m.)
WHERE:	Fairmont Royal York 100 Front Street West Toronto, Ontario

About Innovative Medicines Canada

Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.

SOURCE Innovative Medicines Canada

Sarah Dion-Marquis, Director, Media and Public Relations, Telephone: [phone], E-mail: [email protected]

Related Links

http://innovativemedicines.ca/